undamentalytics Newsletter
Sign in

Heartsciences Inc. revenue

Heartsciences Inc.'s revenue was $4,319 in fiscal 2026, down 0.7% on the year before. Since fiscal 2022 ($14,373) it has grown at a compound -26.0% a year. Over the last twelve months it was $4,519.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026LTMJul 2026
Revenue14519445
Growth on the year before—−64.2%+261.2%−76.6%−0.7%—
Gross profit6213233
Gross margin45.1%45.7%67.3%56.8%59.1%60.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Heartsciences Inc. $4,519 -64.2% —
Cuprina Holdings (cayman) LTD $38,204 5.6% —
Phaos Technology Holdings (cayman) Ltd $102,806 -18.2% —
Pavmed Inc. $112,000 -89.0% -49.6%
Nexalin Technology, Inc. $217,155 24.2% -30.6%
Qtrex Quantum Ltd. $289,000 — —

Compare with peers

Head to head: CUPR vs HSCSHSCS vs POASHSCS vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Heartsciences Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Heartsciences Inc.